Drug Approval | May 04, 2022
Gland launches Bortezomib in the US market
Bortezomib for injection is used to treat certain types of cancer such as multiple myeloma and mantle cell lymphoma
Bortezomib for injection is used to treat certain types of cancer such as multiple myeloma and mantle cell lymphoma
The facility is among 12 centres established worldwide, and the first in Asia
The inspection was triggered by Shilpa's submission of applications for four ANDA's to seek approval to use this site as an alternate testing laboratory
Three RFPs now open for qualified researchers through NORD's Jayne Holtzer rare disease research grants program
As an industrial partner of the IHU, the Medi-Globe Group is thus further expanding its role as an innovation leader in minimally invasive diagnostics and therapies
Blood test for early detection of Alzheimer's Disease (AD) risk will lead to better patient care, physicians say; US. adults call for earlier evaluation and more education
Funds will be allocated to accelerate rapid production and high-end curation of whole genome sequences for its clinical application
CLNK is a biotechnology research and development company that utilizes umbilical cord blood as the raw material to develop innovative, allogeneic, off-the-shelf, cell based therapeutic products
Flagship U.S. facility will include biologic manufacturing and late stage research and clinical development of innovative cancer medicines
South Carolina’s largest health system adopts Philips software solutions for patient monitoring and enterprise imaging, helping to drive interoperability and data analytics, and deliver on Quadruple Aim
Subscribe To Our Newsletter & Stay Updated
